LEICA BIOSYSTEMS NEWCASTLE LIMITED
Company Information
- Company Number
- 02163063
- Registered Address
- Unit 4 Blythe Valley Innovation Centre, Central Boulevard, Blythe Valley Business Park, Solihull, England, B90 8AJ
- Status
- Active
- Employee Count
- 314
- Turnover
- £179,347,000
- EBITDA
- £114,919,000
Additional Details
- Website
- https://leicabiosystems.com
- Company Type
- Private limited Company
- Incorporated On
- 10 September 1987
- Nature of Business
- 74909 - Other professional, scientific and technical activities not elsewhere classified
- Industries
- Professional Services
- Region
- West Midlands
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 25 Jul 2025 | 47 | 16% | 54% | 30% | 81% |
| 01 Jul 2024 - 31 Dec 2024 | 17 Jan 2025 | 48 | 16% | 53% | 31% | 81% |
| 01 Jul 2023 - 31 Dec 2023 | 22 Jan 2024 | 59 | 17% | 50% | 33% | 77% |
| 01 Jan 2023 - 30 Jun 2023 | 25 Jul 2023 | 70 | 14% | 43% | 43% | 83% |
| 01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 70 | 9% | 42% | 49% | 86% |
| 01 Jul 2021 - 31 Dec 2021 | 24 Jan 2022 | 63 | 9% | 46% | 45% | 86% |
| 01 Jan 2021 - 30 Jun 2021 | 23 Jul 2021 | 57 | 11% | 50% | 39% | 83% |
| 01 Jul 2020 - 31 Dec 2020 | 15 Jan 2021 | 59 | 23% | 37% | 40% | 89% |
| 01 Jan 2020 - 30 Jun 2020 | 03 Aug 2020 | 63 | 20% | 36% | 44% | 76% |
| 01 Jan 2019 - 30 Jun 2019 | 11 Jul 2019 | 61 | 18% | 37% | 45% | 69% |
| 01 Jul 2018 - 31 Dec 2018 | 22 Jan 2019 | 65 | 12% | 42% | 46% | 72% |
| 01 Jan 2018 - 30 Jun 2018 | 23 Jul 2018 | 64 | 12% | 43% | 45% | 67% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Payment terms negotiated with individual suppliers and range from 0- 90 days
Were there any changes to the standard payment terms in the reporting period?
Terms are negotiated with suppliers when contracts come up for renewal
Any other information about payment terms
N/A
Maximum contractual payment period agreed
90
Dispute Resolution Process
Invoices are recorded on ERP systems and blocked for payment until dispute resolved liaising with suppliers to try and resolve quickly.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
LEICA BIOSYSTEMS NEWCASTLE LIMITED is a leading company in the medical technology industry, specializing in the development and manufacturing of innovative products for the healthcare sector. The company is committed to sustainability and has implemented various initiatives to reduce its environmental impact.
Their sustainability program includes using green energy sources, reducing waste and promoting recycling, and implementing energy-efficient technologies in their facilities. They also have a strong focus on ethical and responsible business practices, ensuring the well-being of their employees and stakeholders.
The company offers a wide range of products and services, including medical devices, laboratory equipment, and software solutions. Their products are used in various medical fields, such as pathology, genetics, and oncology, to improve patient care and outcomes.
LEICA BIOSYSTEMS NEWCASTLE LIMITED has a team of highly skilled and experienced individuals leading the company, including their CEO, Dr. Ian Barton, and their Chief Financial Officer, Mr. David Mead. They are committed to driving the company's success and promoting a culture of innovation and sustainability.
The company's website, www.leicabiosystems.com, provides detailed information about their products and services, as well as their sustainability efforts. Their registered office address is Leica Biosystems Newcastle Limited, Balliol Business Park West, Benton Lane, Newcastle Upon Tyne, NE12 8EW, United Kingdom.
In summary, LEICA BIOSYSTEMS NEWCASTLE LIMITED is a leading company in the medical technology industry, with a strong focus on sustainability and ethical business practices. They offer innovative products and services, led by a dedicated team of professionals, and can be easily contacted through their website or registered office address.
